Shares of ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) were down 5.5% during trading on Friday . The stock traded as low as $1.3601 and last traded at $1.37. 82,350 shares traded hands during mid-day trading, an increase of 305% from the average daily volume of 20,327 shares. The stock had previously closed at $1.45.
ImmunoPrecise Antibodies Stock Down 5.5%
The firm’s 50-day moving average price is $1.45 and its 200 day moving average price is $1.38.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) is a Canada-based contract research organization specializing in the discovery and development of therapeutic antibodies. The company provides a full suite of preclinical research services, from target validation and lead identification through to humanization and optimization. Its capabilities encompass hybridoma, phage display, single B cell sorting and next-generation sequencing platforms to accelerate antibody candidate selection and characterization.
ImmunoPrecise serves biopharmaceutical and biotechnology partners worldwide, offering customized solutions for projects in immuno-oncology, infectious diseases, autoimmunity and other therapeutic areas.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
